ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$3.87
Tradestie Score
55
Market Cap
$202.58M
Revenue Growth
-0.1%
Analyst Upside
+163.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$14.13
|
$626.91M | - | 59 | Compare |
|
SVRA
Savara Inc.
|
$4.62
|
$611.84M | - | 66 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.41
|
$552.46M | - | 61 | Compare |
|
VSTM
Verastem, Inc.
|
$9.47
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.07
|
$540.97M | - | 65 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.44
|
$529.35M | 11.4 | 62 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.56
|
$512.39M | - | 67 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.85
|
$505.12M | 2.8 | 60 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$96.14
|
$492.21M | - | 53 | Compare |
More ACRS Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry